de Wit M - Search Results

1

Potential time benefit in the assessment of recurrent rat rhabdomyosarcoma using positron emission tomography (PET) with (18)fluorodeoxyglucose depends on therapy-specific growth delay.

Raabe A, Buchert R, Seegers B, de Wit M. Raabe A, et al. Among authors: de wit m. Strahlenther Onkol. 2006 Oct;182(10):610-5. doi: 10.1007/s00066-006-1553-5. Strahlenther Onkol. 2006. PMID: 17013575

2

Time benefit in the assessment of recurrences following fractionated radiotherapy in an experimental tumour system using positron-emission tomography with 18F-fluorodeoxyglucose.

De Wit M, Raabe A, Seegers B, Buchert R, Beck-Bornholdt HP, Alberti W, Hossfeld DK. De Wit M, et al. Int J Radiat Biol. 2004 Jul;80(7):529-39. doi: 10.1080/09553000410001723875. Int J Radiat Biol. 2004. PMID: 15360091

3

Prognostic relevance of FDG PET in patients with neurofibromatosis type-1 and malignant peripheral nerve sheath tumours.

Brenner W, Friedrich RE, Gawad KA, Hagel C, von Deimling A, de Wit M, Buchert R, Clausen M, Mautner VF. Brenner W, et al. Among authors: de wit m. Eur J Nucl Med Mol Imaging. 2006 Apr;33(4):428-32. doi: 10.1007/s00259-005-0030-1. Epub 2006 Jan 11. Eur J Nucl Med Mol Imaging. 2006. PMID: 16404595 Clinical Trial.

4

[Granulation tissue: pitfall in therapy control with F-18-FDG PET after chemotherapy].

Lorenzen J, de Wit M, Buchert R, Igel B, Bohuslavizki KH. Lorenzen J, et al. Among authors: de wit m. Nuklearmedizin. 1999;38(8):333-6. Nuklearmedizin. 1999. PMID: 10615668 German.

5

Low-cost, small-animal shelf for simultaneously assessing several small animals with a whole-body PET scanner.

Buchert R, de Wit M, Raabe A, Bohuslavizki KH, Schulte U, Mester J, Clausen M. Buchert R, et al. Among authors: de wit m. J Nucl Med Technol. 2000 Sep;28(3):171-2. J Nucl Med Technol. 2000. PMID: 11001499 Free article.

6

18FDG-PET following treatment as valid predictor for disease-free survival in Hodgkin's lymphoma.

de Wit M, Bohuslavizki KH, Buchert R, Bumann D, Clausen M, Hossfeld DK. de Wit M, et al. Ann Oncol. 2001 Jan;12(1):29-37. doi: 10.1023/a:1008357126404. Ann Oncol. 2001. PMID: 11249046 Free article. Clinical Trial.

7

Implantable device for intravenous drug delivery in the rat.

de Wit M, Raabe A, Tuinmann G, Hossfeld DK. de Wit M, et al. Lab Anim. 2001 Oct;35(4):321-4. doi: 10.1258/0023677011911903. Lab Anim. 2001. PMID: 11669315

8

[18F]Fluorodeoxyglucose positron emission tomography in nonseminomatous germ cell tumors after chemotherapy: the German multicenter positron emission tomography study group.

Oechsle K, Hartmann M, Brenner W, Venz S, Weissbach L, Franzius C, Kliesch S, Mueller S, Krege S, Heicappell R, Bares R, Bokemeyer C, de Wit M; German Multicenter Positron Emission Tomography Study Group. Oechsle K, et al. Among authors: de wit m. J Clin Oncol. 2008 Dec 20;26(36):5930-5. doi: 10.1200/JCO.2008.17.1157. Epub 2008 Nov 17. J Clin Oncol. 2008. PMID: 19018083

9

[Computerized tomography and F-18-FDG positron emission tomography in staging of malignant lymphomas: a comparison].

Bumann D, de Wit M, Beyer W, Beese M, Lübeck M, Bücheler E, Clausen M. Bumann D, et al. Among authors: de wit m. Rofo. 1998 May;168(5):457-65. doi: 10.1055/s-2007-1015162. Rofo. 1998. PMID: 9617362 German.

10

Whole-body positron emission tomography (PET) for diagnosis of residual mass in patients with lymphoma.

de Wit M, Bumann D, Beyer W, Herbst K, Clausen M, Hossfeld DK. de Wit M, et al. Ann Oncol. 1997;8 Suppl 1:57-60. Ann Oncol. 1997. PMID: 9187431 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

934 results

Search Page

Filters